Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-06-14
2011-06-14
Chong, Kimberly (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S024310, C536S024100, C536S024500
Reexamination Certificate
active
07960363
ABSTRACT:
The present invention provides an agent for treating wound, containing a substance that suppresses the expression or function of PDLIM2. The substance that suppresses the expression or function of PDLIM2 is preferably an siRNA or antisense nucleic acid capable of specifically suppressing the expression of PDLIM2, or an expression vector capable of expressing said polynucleotide. In addition, the present invention provides a method of screening for a substance capable of treating wounds, including determining whether or not a test substance is capable of suppressing the expression or function of PDLIM2.
REFERENCES:
patent: 2006/0177906 (2006-08-01), O'Connor et al.
patent: 2006/0246543 (2006-11-01), Grusby et al.
patent: 2007-254465 (2007-10-01), None
Soutschek et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature vol. 432, 2004 oo:173-178.
Tanaka et al.,Immunity, 22: 729-736 (Jun. 2005).
Tanaka et al.,Nature Immunology, 8(6): 584-591 (Jun. 2007).
Kaisho Tsuneyasu
Tanaka Takashi
Chong Kimberly
Leydig , Voit & Mayer, Ltd.
Riken
LandOfFree
Therapeutic agent for wounds and screening method for the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for wounds and screening method for the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for wounds and screening method for the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2734214